Table of Contents
Thrombosis
Volume 2012 (2012), Article ID 142615, 5 pages
http://dx.doi.org/10.1155/2012/142615
Clinical Study

Anti-Phospholipid Antibodies in Patients Undergoing Total Joint Replacement Surgery

1Department of Clinical Research, Marshfield Clinic Research Foundation, 1000 North Oak Avenue, Marshfield, WI 54449, USA
2Departments of Hematology and Oncology, Orthopedic Surgery, Coagulation Laboratory, Marshfield Clinic, 1000 North Oak Avenue, Marshfield, WI 54449, USA

Received 6 July 2012; Revised 22 September 2012; Accepted 26 September 2012

Academic Editor: Edith Nutescu

Copyright © 2012 Melissa Simpson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Cordell-Smith, S. C. Williams, W. M. Harper, and P. J. Gregg, “Lower limb arthroplasty complicated by deep venous thrombosis. Prevalence and subjective outcome,” Journal of Bone and Joint Surgery B, vol. 86, no. 1, pp. 99–101, 2004. View at Google Scholar · View at Scopus
  2. Y. Falck-Ytter, C. W. Francis, N. A. Johanson et al., “Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, vol. 141, 2, pp. e278S–e325S, 2012. View at Publisher · View at Google Scholar
  3. J. C. Grady-Benson, C. S. Oishi, P. B. Hanson, C. W. Colwell Jr., S. M. Otis, and R. H. Walker, “Routine postoperative duplex ultrasonography screening and monitoring for the detection of deep vein thrombosis: a survey of 110 total hip arthroplasties,” Clinical Orthopaedics and Related Research, no. 307, pp. 130–141, 1994. View at Google Scholar · View at Scopus
  4. W. H. Geerts, J. A. Heit, G. P. Clagett et al., “Prevention of venous thromboembolism,” Chest, vol. 119, supplement 1, pp. 132S–175S, 2001. View at Google Scholar · View at Scopus
  5. M. T. Clarke, J. S. Green, W. M. Harper, and P. J. Gregg, “Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis,” Journal of Bone and Joint Surgery B, vol. 79, no. 5, pp. 787–791, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. G. P. Clagett, F. A. Anderson Jr., J. Heit, M. N. Levine, and H. B. Wheeler, “Prevention of venous thromboembolism,” Chest, vol. 108, no. 4, 1995. View at Google Scholar · View at Scopus
  7. W. H. Geerts, G. F. Pineo, J. A. Heit et al., “Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy,” Chest, vol. 126, supplement 3, pp. 338S–400S, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Januel, G. Chen, C. Ruffieux et al., “Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review,” The Journal of the American Medical Association, vol. 307, pp. 294–303, 2012. View at Publisher · View at Google Scholar
  9. C. Howie, H. Hughes, and A. C. Watts, “Venous thromboembolism associated with hip and knee replacement over a ten-year period. A population-based study,” Journal of Bone and Joint Surgery B, vol. 87, no. 12, pp. 1675–1680, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. N. A. Johanson, P. F. Lachiewicz, J. R. Lieberman et al., “American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty,” Journal of Bone and Joint Surgery A, vol. 91, no. 7, pp. 1756–1757, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Binns and R. Pho, “Femoral vein occlusion during hip arthroplasty,” Clinical Orthopaedics and Related Research, no. 255, pp. 168–172, 1990. View at Google Scholar · View at Scopus
  12. A. Conduah and J. R. Lieberman, “Venous thromboembolic prophylaxis after elective total hip arthroplasty,” Clinical Orthopaedics and Related Research, no. 441, pp. 274–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. S. S. Runchey, A. R. Folsom, M. Y. Tsai, M. Cushman, and P. D. McGovern, “Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study,” British Journal of Haematology, vol. 119, no. 4, pp. 1005–1010, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Bedair, M. Berli, S. Gezer, J. J. Jacobs, and C. J. Della Valle, “Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study,” Clinical Orthopaedics and Related Research, vol. 469, no. 1, pp. 131–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Exner, G. Papadopoulos, and J. Koutts, “Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among ‘lupus anticoagulants’,” Blood Coagulation & Fibrinolysis, vol. 1, no. 3, pp. 259–266, 1990. View at Google Scholar · View at Scopus
  16. D. A. Triplett, L. K. Barna, and G. A. Unger, “A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification,” Thrombosis and Haemostasis, vol. 70, no. 5, pp. 787–793, 1993. View at Google Scholar · View at Scopus
  17. H. Olteanu, K. A. Downes, J. Patel, D. Praprotnik, and R. Sarode, “Warfarin does not interfere with Lupus anticoagulant detection by dilute Russell's viper venom time,” Clinical Laboratory, vol. 55, no. 3-4, pp. 138–142, 2009. View at Google Scholar · View at Scopus
  18. M. Biggioggero and P. L. Meroni, “The geoepidemiology of the antiphospholipid antibody syndrome,” Autoimmunity Reviews, vol. 9, no. 5, pp. A299–A304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Mateo, A. Oliver, M. Borrell, N. Sala, and J. Fontcuberta, “Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism—results of the Spanish multicentric study on thrombophilia (EMET-Study),” Thrombosis and Haemostasis, vol. 77, no. 3, pp. 444–451, 1997. View at Google Scholar · View at Scopus
  20. P. L. Meroni, D. Mari, D. Monti et al., “Anti-beta 2 glycoprotein I antibodies in centenarians,” Experimental Gerontology, vol. 39, no. 10, pp. 1459–1465, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Tripodi, V. Chantarangkul, M. Clerici, and P. M. Mannucci, “Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment: performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA,” Thrombosis and Haemostasis, vol. 88, no. 4, pp. 583–586, 2002. View at Google Scholar · View at Scopus
  22. Y. Zhang, Z. Hua, K. Zhang, K. Meng, and Y. Hu, “Therapeutic effects of anticoagulant agents on preeclampsia in a murine model induced by phosphatidylserine/phosphatidylcholine microvesicles,” Placenta, vol. 30, no. 12, pp. 1065–1070, 2009. View at Publisher · View at Google Scholar · View at Scopus